Abstract:Arshad Hussain, 1 Yijing Wang, 1 Emily Mo, 2 Muhammad Nadeem Khan, 3 Qiangqiang Zhang, 1 Li Li, 1 Junhao Zhu, 1 Min Zhu 1 1 Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, People's Republic of China; 2 Shanghai Medical College, Fudan University, Shanghai, People's Republic of China; 3 Department of Cell Biology & Genetics, Shantou University Medical College, Shantou, People's Republic of China Correspondence: Min Zhu, Email Background and Aim: Infection caused by Aspergillus species poses a growing global concern, yet their prevalence in Southeast China lacks comprehensive documentation. This retrospective analysis aims to elucidate the epidemiological role and antifungal susceptibilities of Aspergillus species at Huashan Hospital of Fudan University, Shanghai, China. Methods: Data spanning from 2018 to 2022, encompassing demographic, clinical, and laboratory information on Aspergillus species isolates were analyzed. The isolates were subjected to susceptibility testing using YeastOne TM broth microdilution system. Results: A total of 253 Aspergillus isolates were identified, with A. fumigatus (57.71%) being the predominant species, followed by A. niger (26.88%), A. flavus (10.67%), and A. terreus (3.95%). Notably, the highest number of isolates originated from the Department of Infectious Disease (28.06%), with sputum (54.94%) being the primary source of isolation, where A. fumigatus was the dominant species. Gastrointestinal disorder (23.90%), hepatic disorder (9.09%), and diabetes (8.30%) were identified as the most prevalent underlying conditions, with A. fumigatus being the most abundant species in each case, accounting for 65.08%, 82.60%, and 73.91%, respectively, followed by A. flavus . Non-wild-type (NWT) Aspergillus isolates exhibited higher resistance against amphotericin B (AMB) compared to triazoles. Specifically, A. fumigatus showed greater resistance to AMB, with only 23.28% of isolates being susceptible, while the majority of isolates were susceptible to triazoles like itraconazole (ITR) and posaconazole (POS). POS demonstrated the highest efficacy against all species. Sequencing revealed mutations in the promoter region of the cyp51A gene and at positions Y121F and E247K in A, fumigatus which confer resistance to ITR, voriconazole (VRC), and POS. Conclusion: These findings contribute to a better understanding of the epidemiology and antifungal resistance pattern of Aspergillus species in the region, providing valuable insights for the management of Aspergillus -related infections. Keywords: Aspergillus , antifungal susceptibility, epidemiology Aspergillus species are commonly found in soil, decaying biological materials, and restrained places, which cause a serious fungal infection known as aspergillosis. 1 Infections caused by these ubiquitous species often challenging to diagnose, and the mortality rate can be as high as 30%–95%. 2 In recent years, the incidence of invasive aspergillosis has increased significantly due to the use of various immunosuppressive agents, the development of organ transplantation, and the increase of AIDS. Among these, Aspergillus fumigatus is the most common species responsible for about 70–80% of human aspergillosis cases. Infections from other species such as A. niger, A. flavus , and A. terreus are also increasing, particularly in individuals with weakened immune systems. 3 The problem of aspergillosis is increasing, provoking a significant risk to global healthcare system. 4 However, the incidence of aspergillosis in China is not well documented, with only a few studies conducted in specific regions, such as the southeast. 5 A 2017 study estimated that there are 3 million global cases of chronic pulmonary aspergillosis and 2.5 million of invasive aspergillosis. 6 Aspergillosis is more likely to affect people with weakened immune systems, such as those with blood cancers, organ transplants, and chronic lung conditions, as well as those who come into contact with environmental factors like dust and mold. 7 One study showed that mortality increased by 60% in COVID-19-infected patients and by 20% in patients with solid organ transplants. 8,9 The common treatment approach for aspergillosis involves the use of triazole antifungal drugs, such as isavuconazole (ICA), itraconazole (ITR), posaconazole (POS), and voriconazole (VRC). 10 In cases where isolates are res -Abstract Truncated-

Patterns of Susceptibility of Aspergillus Isolates Recovered from Patients Enrolled in the Transplant-Associated Infection Surveillance Network

Antifungal resistance mechanisms of Aspergillus.

Molecular Identification of Aspergillus Species Collected for the Transplant-Associated Infection Surveillance Network

Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)

Changes in In Vitro Susceptibility Patterns of Aspergillus to Triazoles and Correlation With Aspergillosis Outcome in a Tertiary Care Cancer Center, 1999–2015

Infections Due to Aspergillus terreus: A Multicenter Retrospective Analysis of 83 Cases

Increased frequency of non-fumigatus Aspergillus species in amphotericin B–or triazole–pre-exposed cancer patients with positive cultures for aspergilli

Factors associated with mortality in transplant patients with invasive aspergillosis

Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program

Spectrum And Risk Factors For Invasive Candidiasis And Non-Candida Fungal Infections After Liver Transplantation

Invasive Pulmonary Aspergillosis in Lung Transplant Recipients: Retrospective Clinical Analysis from a Tertiary Transplant Center

In Vitro Susceptibilities of Worldwide Isolates of Intrapulmonary Aspergillus Species and Important Candida Species in Sterile Body Sites against Important Antifungals: Data from the Antimicrobial Testing Leadership and Surveillance Program, 2017–2020

Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001–2006

Surveillance of Amphotericin B and Azole Resistance in Aspergillus Isolated from Patients in a Tertiary Teaching Hospital

Multi-Locus Microsatellite Typing of Colonising and Invasive Aspergillus fumigatus Isolates from Patients Post Lung Transplantation and with Chronic Lung Disease

A 20-Year Antifungal Susceptibility Surveillance (from 1999 to 2019) for Aspergillus Spp. and Proposed Epidemiological Cutoff Values for Aspergillus Fumigatus and Aspergillus Flavus: A Study in a Tertiary Hospital in China

Aspergillus fumigatus Variant with Decreased Susceptibility to Multiple Antifungals

Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001–2006: overview of the Transplant-Associated Infection …

Risk Factors and Outcomes of Invasive Aspergillosis in Kidney Transplant Recipients: A Case-Control Study of United States Renal Data System Data

Epidemiology and Antifungal Susceptibilities of Clinically Isolated Aspergillus Species in Tertiary Hospital of Southeast China

Aspergillosis caused by non-fumigatus Aspergillus species: risk factors and in vitro susceptibility compared with Aspergillus fumigatus